383 related articles for article (PubMed ID: 10971445)
1. Autoantibodies to the flavoprotein subunit of succinate dehydrogenase: analysis of specificity in autoimmune thyroid disease.
Kemp EH; Ridgway JN; Smith KA; Watson PF; Weetman AP
Clin Endocrinol (Oxf); 2000 Sep; 53(3):291-9. PubMed ID: 10971445
[TBL] [Abstract][Full Text] [Related]
2. Serum antibodies against the flavoprotein subunit of succinate dehydrogenase are sensitive markers of eye muscle autoimmunity in patients with Graves' hyperthyroidism.
Gunji K; De Bellis A; Kubota S; Swanson J; Wengrowicz S; Cochran B; Ackrell BA; Salvi M; Bellastella A; Bizzarro A; Sinisi AA; Wall JR
J Clin Endocrinol Metab; 1999 Apr; 84(4):1255-62. PubMed ID: 10199764
[TBL] [Abstract][Full Text] [Related]
3. The 64-kilodalton eye muscle protein is the flavoprotein subunit of mitochondrial succinate dehydrogenase: the corresponding serum antibodies are good markers of an immune-mediated damage to the eye muscle in patients with Graves' hyperthyroidism.
Kubota S; Gunji K; Ackrell BA; Cochran B; Stolarski C; Wengrowicz S; Kennerdell JS; Hiromatsu Y; Wall J
J Clin Endocrinol Metab; 1998 Feb; 83(2):443-7. PubMed ID: 9467555
[TBL] [Abstract][Full Text] [Related]
4. Study of serum antibodies against three eye muscle antigens and the connective tissue antigen collagen XIII in patients with Graves' disease with and without ophthalmopathy: correlation with clinical features.
Gopinath B; Musselman R; Adams CL; Tani J; Beard N; Wall JR
Thyroid; 2006 Oct; 16(10):967-74. PubMed ID: 17042681
[TBL] [Abstract][Full Text] [Related]
5. Significance of serum antibodies reactive with flavoprotein subunit of succinate dehydrogenase in thyroid associated orbitopathy.
Hosal BM; Swanson JK; Thompson CR; Kubota S; Gunji K; Kennerdell JS; Wall JR
Br J Ophthalmol; 1999 May; 83(5):605-8. PubMed ID: 10216063
[TBL] [Abstract][Full Text] [Related]
6. Eye muscle antibodies and subtype of thyroid-associated ophthalmopathy.
Kaspar M; Archibald C; De BA; Li AW; Yamada M; Chang CH; Kahaly G; Wall JR
Thyroid; 2002 Mar; 12(3):187-91. PubMed ID: 11952037
[TBL] [Abstract][Full Text] [Related]
7. Thyroid-associated ophthalmopathy in black South African patients with Graves' disease: relationship to antiflavoprotein antibodies.
Joffe B; Gunji K; Panz V; Zouvanis M; Swanson J; Ackrell BA; Wall JR
Thyroid; 1998 Nov; 8(11):1023-7. PubMed ID: 9848717
[TBL] [Abstract][Full Text] [Related]
8. Cloning and characterization of the novel thyroid and eye muscle shared protein G2s: autoantibodies against G2s are closely associated with ophthalmopathy in patients with Graves' hyperthyroidism.
Gunji K; De Bellis A; Li AW; Yamada M; Kubota S; Ackrell B; Wengrowicz S; Bellastella A; Bizzarro A; Sinisi A; Wall JR
J Clin Endocrinol Metab; 2000 Apr; 85(4):1641-7. PubMed ID: 10770210
[TBL] [Abstract][Full Text] [Related]
9. Immunoglobulin A class fibroblast antibodies in patients with Graves' disease and pretibial myxedema.
Arnold K; Metcalfe R; Weetman AP
J Clin Endocrinol Metab; 1995 Dec; 80(12):3430-7. PubMed ID: 8530579
[TBL] [Abstract][Full Text] [Related]
10. Presence of antibodies in the sera of patients with Graves' disease recognizing a 23 kilodalton fibroblast protein.
Bahn RS; Gorman CA; Johnson CM; Smith TJ
J Clin Endocrinol Metab; 1989 Sep; 69(3):622-8. PubMed ID: 2760173
[TBL] [Abstract][Full Text] [Related]
11. Antibodies targeting the calcium binding skeletal muscle protein calsequestrin are specific markers of ophthalmopathy and sensitive indicators of ocular myopathy in patients with Graves' disease.
Gopinath B; Musselman R; Beard N; El-Kaissi S; Tani J; Adams CL; Wall JR
Clin Exp Immunol; 2006 Jul; 145(1):56-62. PubMed ID: 16792674
[TBL] [Abstract][Full Text] [Related]
12. Detection of binding and blocking autoantibodies to the human sodium-iodide symporter in patients with autoimmune thyroid disease.
Ajjan RA; Kemp EH; Waterman EA; Watson PF; Endo T; Onaya T; Weetman AP
J Clin Endocrinol Metab; 2000 May; 85(5):2020-7. PubMed ID: 10843191
[TBL] [Abstract][Full Text] [Related]
13. Eye muscle antibodies in patients with ocular myasthenia gravis: possible mechanism for eye muscle inflammation in acetylcholine-receptor antibody-negative patients.
Gunji K; Skolnick C; Bednarczuk T; Benes S; Ackrell BA; Cochran B; Kennerdell JS; Wall JR
Clin Immunol Immunopathol; 1998 Jun; 87(3):276-81. PubMed ID: 9646837
[TBL] [Abstract][Full Text] [Related]
14. Antithyroglobulin monoclonal and autoantibodies cross-react with an orbital connective tissue membrane antigen: a possible mechanism for the association of ophthalmopathy with autoimmune thyroid disorders.
Kuroki T; Ruf J; Whelan L; Miller A; Wall JR
Clin Exp Immunol; 1985 Nov; 62(2):361-70. PubMed ID: 3841305
[TBL] [Abstract][Full Text] [Related]
15. Antibody-dependent cell-mediated cytotoxicity against orbital target cells in thyroid-associated ophthalmopathy and related disorders; close relationship between serum cytotoxic antibodies and parameters of eye muscle dysfunction.
Barsouk A; Peele KA; Kiljanski J; Stolarski C; Nebes V; Kennerdell JS; Volpe R; Wall JR
J Endocrinol Invest; 1996 Jun; 19(6):334-41. PubMed ID: 8844451
[TBL] [Abstract][Full Text] [Related]
16. Significance of tissue specific and tissue non specific autoimmune reactions of Graves' disease.
Kiljanski J; Nebes V; Wall JR
Clin Exp Rheumatol; 1996; 14 Suppl 15():S69-76. PubMed ID: 8828951
[TBL] [Abstract][Full Text] [Related]
17. Antibodies against striated muscle, connective tissue and nuclear antigens in patients with thyroid-associated ophthalmopathy: should Graves' disease be considered a collagen disorder?
Kiljanski JI; Peele K; Stachura I; Pickeral J; Stolarski C; Kennerdell JS; Wall JR
J Endocrinol Invest; 1997 Nov; 20(10):585-91. PubMed ID: 9438915
[TBL] [Abstract][Full Text] [Related]
18. Peripheral blood T lymphocyte sensitisation against calsequestrin and flavoprotein in patients with Graves' ophthalmopathy.
Nguyen B; Gopinath B; Tani J; Wescombe L; Wall JR
Autoimmunity; 2008 Aug; 41(5):372-6. PubMed ID: 18568642
[TBL] [Abstract][Full Text] [Related]
19. [Muscle antigens recognized with autoantibodies in patients with Graves' ophthalmopathy].
Adler G
Endokrynol Pol; 1992; 43(1 Suppl):1-61. PubMed ID: 1345558
[TBL] [Abstract][Full Text] [Related]
20. Pretibial myxedema: pathophysiology and treatment options.
Fatourechi V
Am J Clin Dermatol; 2005; 6(5):295-309. PubMed ID: 16252929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
